Max Konig
@maxkonigmd.bsky.social
Rheumatologist/ Assistant Prof at Johns Hopkins | Director, Cellular Therapy Program (Autoimmunity) | Advancing precision immunotherapies for autoimmune diseases (https://www.koniglab.org). 🇩🇪🇺🇸
Reposted by Max Konig
@biorxivpreprint.bsky.social Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells
www.biorxiv.org/content/10.1...
Great work @maxkonigmd.bsky.social
www.biorxiv.org/content/10.1...
Great work @maxkonigmd.bsky.social
October 21, 2025 at 1:33 AM
@biorxivpreprint.bsky.social Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells
www.biorxiv.org/content/10.1...
Great work @maxkonigmd.bsky.social
www.biorxiv.org/content/10.1...
Great work @maxkonigmd.bsky.social
Reposted by Max Konig
Your Orwellian Government at work - National Cancer Institute Employees Can’t Publish Information on These Topics Without Special Approval #NIH
www.propublica.org/article/nati...
www.propublica.org/article/nati...
March 23, 2025 at 10:46 AM
Your Orwellian Government at work - National Cancer Institute Employees Can’t Publish Information on These Topics Without Special Approval #NIH
www.propublica.org/article/nati...
www.propublica.org/article/nati...
Reposted by Max Konig
The #RheumMadness podcast is back! Join us as we discuss the T'd Up T-Cells Region, including:
-BiTEs with @maxkonigmd.bsky.social
-CD40L inhibitor for #Sjogren's with Duke rheum
-Abatacept for pre-RA with Allegheny rheum
rheummadness.buzzsprout.com/1465681/epis...
-BiTEs with @maxkonigmd.bsky.social
-CD40L inhibitor for #Sjogren's with Duke rheum
-Abatacept for pre-RA with Allegheny rheum
rheummadness.buzzsprout.com/1465681/epis...
5.2 T'd Up T-Cells - RheumMadness Podcast
In this episode, we dive in to the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational. This is the first of a two-part conversation with the authors of the scouting reports ...
rheummadness.buzzsprout.com
January 9, 2025 at 9:15 PM
The #RheumMadness podcast is back! Join us as we discuss the T'd Up T-Cells Region, including:
-BiTEs with @maxkonigmd.bsky.social
-CD40L inhibitor for #Sjogren's with Duke rheum
-Abatacept for pre-RA with Allegheny rheum
rheummadness.buzzsprout.com/1465681/epis...
-BiTEs with @maxkonigmd.bsky.social
-CD40L inhibitor for #Sjogren's with Duke rheum
-Abatacept for pre-RA with Allegheny rheum
rheummadness.buzzsprout.com/1465681/epis...
Reposted by Max Konig
Findings highlight ‘critical importance’ of infectious complications after CAR-T - read HemeOncToday interview with Kai Rejeski and me #medsky #CARTcells www.healio.com/news/hematol...
Findings highlight ‘critical importance’ of infectious complications after CAR-T
Infections are the primary cause of nonrelapse mortality among individuals who undergo chimeric antigen receptor T-cell therapy, according to study results.Unique CAR-T-specific side effects — s...
www.healio.com
November 18, 2024 at 3:51 AM
Findings highlight ‘critical importance’ of infectious complications after CAR-T - read HemeOncToday interview with Kai Rejeski and me #medsky #CARTcells www.healio.com/news/hematol...
Targeting autoreactive TRBV9+ T cells using TRBV9xCD3 bispecific T cell engaging antibodies. Controlling ankylosing spondylitis and celiac disease without increasing the risk of infection? Let's go. Join us at Room 150, 3:00 PM. #precisionimmunotherapy #ACR24
November 17, 2024 at 7:16 PM
Targeting autoreactive TRBV9+ T cells using TRBV9xCD3 bispecific T cell engaging antibodies. Controlling ankylosing spondylitis and celiac disease without increasing the risk of infection? Let's go. Join us at Room 150, 3:00 PM. #precisionimmunotherapy #ACR24
While at it, if you are interested in learning more about off-the-shelf precision immunotherapies for the treatment of lupus, please join our talk on 9G4xCD3 T cell-engaging antibodies during the SLE - Cellular Therapy Session at 3 PM. #ACR24
November 17, 2024 at 4:37 PM
While at it, if you are interested in learning more about off-the-shelf precision immunotherapies for the treatment of lupus, please join our talk on 9G4xCD3 T cell-engaging antibodies during the SLE - Cellular Therapy Session at 3 PM. #ACR24
Congrats to Jin Liu for being awarded the ACR Emerging Investigator Excellence Award for her work on 9G4-targeted CAR/cTCR-T cells for the treatment of lupus. Join her talk today in the SLE - Cellular Therapy Session at 3 PM. #ACR24 #ProundMentorMoment
November 17, 2024 at 4:36 PM
Congrats to Jin Liu for being awarded the ACR Emerging Investigator Excellence Award for her work on 9G4-targeted CAR/cTCR-T cells for the treatment of lupus. Join her talk today in the SLE - Cellular Therapy Session at 3 PM. #ACR24 #ProundMentorMoment
Congrats to Steph Glavaris for being awarded the ACR Emerging Investigator Excellence Award for her work on T cell-engaging antibodies to deeply deplete TRBV9+, autoreactive T cells in ankylosing spondylitis and celiac disease. #ACR24 #ProundMentorMoment
November 17, 2024 at 4:35 PM
Congrats to Steph Glavaris for being awarded the ACR Emerging Investigator Excellence Award for her work on T cell-engaging antibodies to deeply deplete TRBV9+, autoreactive T cells in ankylosing spondylitis and celiac disease. #ACR24 #ProundMentorMoment